2-isopropyl-1,3-butanediol | 66567-04-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-isopropyl-1,3-butanediol
• 英文别名: 2-i-propyl-1,3-butanediol；2-isopropyl-butane-1,3-diol；2-Methyl-3-hydroxymethyl-pentanol-(4)；2-Isopropyl-butan-1,3-diol；2-Isopropyl-1,3-butandiol；2-Isopropylbutandiol-1,3；2-propan-2-ylbutane-1,3-diol
• CAS: 66567-04-2
• 化学式: C₇H₁₆O₂
• 分子量: 132.203
• InChiKey: KWMHZRGWEGBCTJ-UHFFFAOYSA-N

物化性质

• 沸点：
  106 °C(Press: 4 Torr)
• 密度：
  0.942±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-isopropyl-1,3-butanediol 生成 [3-methyl-2-[1-(4-methylphenyl)sulfonyloxyethyl]butyl] 4-methylbenzenesulfonate
  参考文献：
  名称：

  SQUILLACOTE, MICHAEL;SEMPLE, THOMAS C., J. AMER. CHEM. SOC., 112,(1990) N4, C. 5546-5551

  摘要：

  DOI：
• 作为产物：
  描述：

  异戊醛 在 乙醚 、 potassium carbonate 作用下， 生成 2-isopropyl-1,3-butanediol
  参考文献：
  名称：

  Marvel; Myers; Saunders, Journal of the American Chemical Society, 1948, vol. 70, p. 1697

  摘要：

  DOI：

文献信息

• INDAZOLE DERIVATIVES
  申请人：Buchler Ingrid Price

  公开号：US20110028447A1

  公开（公告）日：2011-02-03

  This invention relates to compounds, pharmaceutical compositions and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a therapeutically effective amount of the compound of formula (I) wherein R 1 , R 2 and R 3 are as defined in this specification.

  这项发明涉及化合物、药物组合物和治疗由CB1受体活性介导的哺乳动物主体（包括人类）疾病的方法，包括向需要这种治疗的哺乳动物中施用化合物的治疗有效剂量，其化合物的结构式为（I），其中R1、R2和R3如本说明书中所定义。
• QUINAZOLINE COMPOUNDS AS SODIUM CHANNEL BLOCKERS
  申请人：Purdue Pharma L.P.

  公开号：US20150250789A1

  公开（公告）日：2015-09-10

  The invention relates to aryl substituted quinazolines of Formula I, and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein G, A, and R 1 -R 4 are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula I to treat a disorder responsive to the blockade of sodium channels. Compounds of the present invention are especially useful for treating pain.

  本发明涉及式I的芳基取代喹唑啉，以及其药学上可接受的盐、前药或溶剂化物，其中G、A和R1-R4如规范中所述。本发明还指向使用式I的化合物来治疗对钠通道阻滞有反应的疾病。本发明的化合物特别适用于治疗疼痛。
• A polyester laminated film
  申请人：Toyo Boseki Kabushiki Kaisha

  公开号：EP0379190A2

  公开（公告）日：1990-07-25

  A polyester laminated film with excellent sealing ability is provided. The polyester laminated film comprises a base film of a polyester resin and a sealing film of a polyester composition, said sealing film being disposed on at least one side of said base film, wherein the sealing energy, which is measured when two pieces of said laminated films are joined together with the respective sealing films facing each other, is 300 g.cm/15 mm or more.

  本发明提供了一种具有优异密封能力的聚酯复合膜。该聚酯复合膜由聚酯树脂基膜和聚酯成分密封膜组成，所述密封膜至少位于所述基膜的一侧，其中，当两片所述复合膜连接在一起，且各自的密封膜面对面时，测得的密封能为 300 g.cm/15 mm 或更高。
• Thermoplastic elastomer compositions
  申请人：GENERAL ELECTRIC COMPANY

  公开号：EP0400323A2

  公开（公告）日：1990-12-05

  Block copolymers of polycarbonate resin and a polyester derived from a dimer fatty acid and a selected class of organic diol exhibit thermoplastic and elastomeric properties. They are useful compositions for molding articles such as automotive parts.

  聚碳酸酯树脂与聚酯的嵌段共聚物由二聚体脂肪酸和一类选定的有机二元醇衍生而成，具有热塑性和弹性特性。它们是用于模塑汽车零件等物品的有用成分。
• Hindered-hydroxyl functional (meth)acrylate esters, copolymers containing them and compositions including same
  申请人：UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION

  公开号：EP0594109A1

  公开（公告）日：1994-04-27

  This invention relates to hindered-hydroxyl functional (meth)acrylate compounds and derivatives thereof and to processes for the preparation thereof. This invention also relates to hindered-hydroxyl functional (meth)acrylate-containing copolymers and to compositions including same. The hindered-hydroxyl functional (meth)acrylate-containing copolymers have utility in coatings, adhesives, inks, sealants, as well as in other end uses.

  本发明涉及受阻羟基官能团(甲基)丙烯酸酯化合物及其衍生物，以及其制备工艺。本发明还涉及含受阻羟基官能团（甲基）丙烯酸酯共聚物和包括其在内的组合物。含受阻羟基官能团（甲基）丙烯酸酯共聚物可用于涂料、粘合剂、油墨、密封剂以及其他最终用途。